Production (Stage)
HealthEquity, Inc.
HQY
$94.52
-$2.67-2.75%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 19.21% | 20.03% | 18.47% | 17.19% | 15.80% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 19.21% | 20.03% | 18.47% | 17.19% | 15.80% |
| Cost of Revenue | 12.36% | 12.09% | 6.17% | 2.83% | 2.74% |
| Gross Profit | 23.16% | 24.83% | 26.22% | 26.75% | 24.96% |
| SG&A Expenses | 6.83% | 21.90% | 17.96% | 16.61% | 16.14% |
| Depreciation & Amortization | 19.12% | 20.61% | 16.59% | 10.66% | 1.16% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.37% | 14.40% | 9.81% | 7.71% | 7.07% |
| Operating Income | 67.59% | 58.33% | 89.66% | 113.83% | 133.22% |
| Income Before Tax | 56.46% | 54.63% | 155.43% | 623.31% | 1,079.44% |
| Income Tax Expenses | 79.09% | 0.02% | 17.89% | 376.94% | 1,198.95% |
| Earnings from Continuing Operations | 51.44% | 73.58% | 231.86% | 723.95% | 1,056.37% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 51.44% | 73.58% | 231.86% | 723.95% | 1,056.37% |
| EBIT | 67.59% | 58.33% | 89.66% | 113.83% | 133.22% |
| EBITDA | 36.03% | 29.91% | 38.30% | 39.34% | 33.72% |
| EPS Basic | 50.09% | 71.47% | 227.84% | 715.28% | 1,034.70% |
| Normalized Basic EPS | 78.25% | 80.52% | 162.72% | 290.78% | 732.87% |
| EPS Diluted | 49.23% | 71.31% | 224.58% | 723.70% | 980.56% |
| Normalized Diluted EPS | 77.95% | 79.79% | 161.27% | 287.26% | 729.41% |
| Average Basic Shares Outstanding | 1.16% | 1.53% | 1.70% | 1.60% | 1.45% |
| Average Diluted Shares Outstanding | 1.46% | 2.08% | 2.54% | 2.87% | 2.76% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |